Skip to main content
Caplight Logo









Medmain Inc.

Medmain Inc.

Private
FukuokaHealthcare & Life Scienceshttps://medmain.com/

Last Round

M&A

Apr 30, 2026

Est. Valuation

$26.7M

Total Funding Raised

$20.1M

Company Overview

Medmain Inc. is a healthtech company that develops and provides 'PidPort', an AI-powered cloud system to assist in digital pathology.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, Computer Vision, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

digital pathologypathology AIdiagnostic supporttelepathologypathology softwarecancer diagnosticsmedical imagingdeep learningpathology lab automationcomputational pathologypathology workflowpathology DXvirtual slidespathology SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Medmain Inc. Comparables

Compare Medmain Inc. with similar companies based on industry and business-model similarity.

Medmain Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
N Lab Inc.
82%
aetherAI
81%
MindPeak
80%

Medmain Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AApr 30, 2026
Early FundingMay 8, 2025
Series A ExtensionApr 18, 2024
Series AAug 24, 2020
SeedAug 17, 2018

Key People

Founding team and executive leadership

Osamu Iizuka

CEO & Founder

Founding Team

Medmain Inc. Investors

Notable investors and investment history

Medmain Inc. investors
InvestorRounds
MIRAISOZO INVESTMENTS Inc.Series A
DEEPCORE Inc.Seed, Series A
Plug and Play Tech CenterEarly Funding
One CapitalEarly Funding
エンジェルナビ・キャピタル株式会社Series A Extension
Hike VenturesSeries A
Beta Venture CapitalSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors increased 83% MoM.

  • Apr 18, 2024

    Raised $5.5M with participation from Nikon and PSP Corporation.

Medmain Inc. Filings

Explore SEC and related filing metadata, where available.

Medmain Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Medmain Inc.'s valuation, stock price, and market status.

Is Medmain inc. a public or private company?

Medmain inc. is a private company.

What is the current stock price of Medmain inc.?

Medmain inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Medmain inc. worth (valuation)?

Medmain inc.'s valuation is estimated at $26.7M based on funding round data.

Can I buy Medmain inc. stock?

Medmain inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Medmain inc.'s last funding round?

Medmain inc.'s most recent funding round was M&A on April 30, 2026.

Who are the main investors in Medmain inc.?

Key investors in Medmain inc. include One Capital.

Will Medmain inc. IPO soon?

No public IPO plans have been announced for Medmain inc..

How can I track Medmain inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Medmain inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFukuoka
Employee Range13
Year Founded2018
Last FundingApr 30, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?